Reva touts first implant of Fantom Encore bioresorbable scaffold in Italy

This article was originally published here

Reva MedicalReva Medical (ASX:RVA) touted this week the first implant of its newly-launched Fantom Encore bioresorbable scaffold in Italy.

The company’s third-generation coronary bioresorbable scaffold features a thin strut profile and Reva’s Tyrocore polymer.

Get the full story at our sister site, Drug Delivery Business News.

The post Reva touts first implant of Fantom Encore bioresorbable scaffold in Italy appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply